BridgeMD
Tests treatment safety and results for Common Wart
Official title Randomized, Placebo-controlled, Double Blind Study to Evaluate the Efficacy of 2LVERU®JUNIOR and 2LVERU® on the Treatment of Warts
ClinicalTrials.gov ID: NCT03977753
What this study is testing
What is 2LVERU® or 2LVERU® JUNIOR?
2LVERU® or 2LVERU® JUNIOR is an investigational medicine, given as a pill taken by mouth, being studied as a potential treatment for common wart.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- Human papillomavirus (HPV) infection is very common, as most people will experience infection during their lifetime. The most common manifestation of HPV infection is common warts.
- Phase 4: studies an already-approved treatment
- You might receive a placebo (an inactive treatment) instead of the study drug, decided by chance. You may not know which one you got.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 3 and older
You may be able to join if
- Patients, male or female, aged 3 years and older,
- Patients with common warts (Verruca vulgaris), and/or plantar warts (Verruca plantaris), and/or flat warts (Verruca plana),
- Patients (and/or parents if necessary) having the faculties to understand and respect the constraints of the study,
- Signature of the Informed Consent Form by the patient (and/or parents if necessary).
You likely can't join if
- Patients who have received any curative warts treatment in the previous 2 months prior to the study,
- Patients who have received any homeopathic treatment in the previous 2 months prior to the study,
- Patients under immunosuppressive treatment,
- Patients having received immunotherapy or micro-immunotherapy during the last 6 months,
- Patients with known lactose intolerance,
- Pregnant or breastfeeding women,
See the full eligibility criteria
- Patients, male or female, aged 3 years and older,
- Patients with common warts (Verruca vulgaris), and/or plantar warts (Verruca plantaris), and/or flat warts (Verruca plana),
- Patients (and/or parents if necessary) having the faculties to understand and respect the constraints of the study,
- Signature of the Informed Consent Form by the patient (and/or parents if necessary).
- Patients who have received any curative warts treatment in the previous 2 months prior to the study,
- Patients who have received any homeopathic treatment in the previous 2 months prior to the study,
- Patients under immunosuppressive treatment,
- Patients having received immunotherapy or micro-immunotherapy during the last 6 months,
- Patients with known lactose intolerance,
- Pregnant or breastfeeding women,
- Patients who participated in a clinical study in the previous 2-months period,
- Patients (and/or parents of patients if necessary) who are not sufficiently motivated to engage on the total study follow-up period, or likely to travel or to move before the end of the study,
- Patients with severe immunodeficiency disease requiring long term treatment (\ ) or patients under chemotherapy or radiotherapy,
- Patients under listed homeopathic or phytotherapy treatment (see protocol),
- Patients addicted to or using recreational drugs,
- Patient under guardianship and/or curators, (\ ) important renal or respiratory insufficiency, transplanted or grafted patients, HIV/AIDS, terminal cancer.
The study team makes the final eligibility decision.
Where it's taking place
- Arlon, Belgium
- Bouge, Belgium
- Brussels, Belgium
- Écaussinnes-d'Enghien, Belgium
- Fontaine l'Êveque, Belgium
- Ghent, Belgium
- Gozée, Belgium
- Hamme-Mille, Belgium
- Juprelle, Belgium
- Mons, Belgium
- Namur, Belgium
- Oisquercq, Belgium
- Plancenoit, Belgium
- Quiévrain, Belgium
- Saint-Symphorien, Belgium
- Seneffe, Belgium
- Wavre, Belgium
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 3 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Arlon, Belgium; Bouge, Belgium; Brussels, Belgium; Écaussinnes-d'Enghien, Belgium; Fontaine l'Êveque, Belgium; Ghent, Belgium and 11 more location(s). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.